Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®

Summary

This is an extension study to evaluate the safety and tolerability of long-term treatment with DiaPep277® and to determine the long-term treatment effect of DiaPep277® on parameters of metabolic control and on preservation of beta-cell function in subjects who have long exposure to DiaPep277®.

Timeline

Start

2013-10

Primary completion

2014-09

Completion

2014-12

Outcome

Outcome not reported

Stopped: “A corporate decision to suspend development of DiaPep277®”

Drugs

Indications